Figure 3.

Surface under the cumulative ranking curve expressed as percentages ranking therapeutic effects of treatments for Crohn disease patients with low bone mineral density (BMD). The surface under the cumulative ranking area of each bar represents the probability size of each treatment. The color of the bar represents the specific therapeutic schedule. The abscissa represents the therapeutic probability of various drugs and the ordinate denotes the outcomes about the change of BMD and the incidence of adverse events. For the change of BMD, the pharmacological agent with the longest bar means the most efficacious treatment while agent with the shortest bar indicates the worest one. Oppositely, for the incidence of adverse events, the pharmacological agent with the shortest bar means the most safety treatment while agent with the longest bar indicates the worest one. LSBMD = lumbar spine bone mineral density, THBMD = total hip bone mineral density.